BBIO ▲ +0.5% - BridgeBio Pharma, Inc. $BBIO - Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records 11-OCT-2026 02:30 PM ET